Related Articles
Michael Hewson, chief market analyst at CMC Markets UK, takes a retrospective look at the IPO and analyses the future challenges facing the company.
More: continued here
About admin
Check Also
Alliance Pharma agrees £350m takeover by fund manager
Alliance Pharma said its investors would receive 62.5p per share under the deal DBAY believes …